NGVT241220C50000
- 1.70
- 0.000.00%
Ingevity Newsroom
Is Ingevity (NGVT) Stock Undervalued Right Now?
Does Ingevity (NYSE:NGVT) Have A Healthy Balance Sheet?
Express News | Ingevity Corp - Board Now Includes Nine Directors, Eight Independent
Express News | Ingevity Elects Kevin Willis to Its Board of Directors
Ingevity Corporation (NGVT): The Small Cap Chemical Stock Hedge Funds Are Watching Closely
Ingevity (NGVT) Gets a Hold From Wells Fargo
Here's Why You Should Retain Mosaic Stock in Your Portfolio
Here's Why You Should Hold Onto Air Products Stock for Now
Why Is Ingevity (NGVT) Up 14.6% Since Last Earnings Report?
CF Industries Shares Scale 52-Week High: What's Driving the Stock?
SouthernSun Small Cap Strategy Is Evaluating Its Position in Ingevity Corporation (NGVT) Amid Strategic Changes and Management Transitions
Should Value Investors Buy Ingevity (NGVT) Stock?
Ingevity Price Target Raised to $47.00/Share From $40.00 by BMO Capital
Ingevity Is Maintained at Market Perform by BMO Capital
Ingevity Analyst Ratings
Ingevity Corporation (NGVT) Q3 2024 Earnings Call Transcript Summary
Ingevity | 10-Q: Q3 2024 Earnings Report
Ingevity Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Adjusted EPS Results.
Ingevity (NYSE:NGVT) Adds US$109m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 61%
BMO Capital Maintains Ingevity(NGVT.US) With Hold Rating, Cuts Target Price to $40